RDNT vs. FTRE, GH, VCYT, VRDN, FLGT, CSTL, CDNA, GTH, BDSX, and BNR
Should you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fortrea (FTRE), Guardant Health (GH), Veracyte (VCYT), Viridian Therapeutics (VRDN), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), CareDx (CDNA), Genetron (GTH), Biodesix (BDSX), and Burning Rock Biotech (BNR).
RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings.
RadNet has higher earnings, but lower revenue than Fortrea.
In the previous week, RadNet had 1 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for RadNet and 4 mentions for Fortrea. Fortrea's average media sentiment score of 1.25 beat RadNet's score of 0.61 indicating that Fortrea is being referred to more favorably in the news media.
RadNet presently has a consensus target price of $53.67, indicating a potential upside of 10.88%. Fortrea has a consensus target price of $37.29, indicating a potential upside of 2.57%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than Fortrea.
RadNet has a net margin of 0.19% compared to Fortrea's net margin of 0.00%. RadNet's return on equity of 4.72% beat Fortrea's return on equity.
RadNet received 334 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 65.83% of users gave RadNet an outperform vote while only 38.46% of users gave Fortrea an outperform vote.
77.9% of RadNet shares are owned by institutional investors. 4.4% of RadNet shares are owned by insiders. Comparatively, 0.1% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
RadNet beats Fortrea on 12 of the 15 factors compared between the two stocks.
Get RadNet News Delivered to You Automatically
Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
